Drugs targeting protease-activated receptor-4 improve the anti-thrombotic therapeutic window

被引：6
|
作者：
French, Shauna L. [1 ]
Hamilton, Justin R. [1 ]
机构：
[1] Monash Univ, Australian Ctr Blood Dis, L2,AMREP Bldg,Alfred Commercial Rd, Melbourne, Vic 3004, Australia
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2017年 / 5卷 / 23期
基金：
英国医学研究理事会;
关键词：
ACUTE CORONARY SYNDROMES; MYOCARDIAL-INFARCTION; ANTAGONIST VORAPAXAR; PLATELET ACTIVATION; INTERVENTION; INHIBITION; PREVENTION; TRIAL;
D O I：
10.21037/atm.2017.09.10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules
    Muro, S
    Muzykantov, VR
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (18) : 2383 - 2401
  • [22] Differential Signaling by Protease-Activated Receptors: Implications for Therapeutic Targeting
    Sidhu, Tejminder S.
    French, Shauna L.
    Hamilton, Justin R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (04) : 6169 - 6183
  • [23] Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding
    Wong, Pancras C.
    Seiffert, Dietmar
    Bird, J. Eileen
    Watson, Carol A.
    Bostwick, Jeffrey S.
    Giancarli, Mary
    Allegretto, Nick
    Hua, Ji
    Harden, David
    Guay, Jocelyne
    Callejo, Mario
    Miller, Michael M.
    Lawrence, R. Michael
    Banville, Jacques
    Guy, Julia
    Maxwell, Brad D.
    Priestley, E. Scott
    Marinier, Anne
    Wexler, Ruth R.
    Bouvier, Michel
    Gordon, David A.
    Schumacher, William A.
    Yang, Jing
    SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (371)
  • [24] Protease-Activated Receptor-4 (PAR4) Inhibits Pro-Nociceptive Signals and Visceral Hypersensitivity
    Auge, Celine
    Cenac, Nicolas
    Balz-Hara, Daniela
    Vergnolle, Nathalie
    GASTROENTEROLOGY, 2009, 136 (05) : A722 - A722
  • [25] Role of protease-activated receptor-4 in the phosphorylation of extracellular regulated kinase in vascular smooth muscle cells
    Epperson, Tenille
    Tillery, Lakeisha
    Mantey, Jane
    Austin, Anita
    Motley, Evangeline
    FASEB JOURNAL, 2011, 25
  • [26] Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation
    Slofstra, Sjoukje H.
    Bijlsma, Maarten F.
    Groot, Angelique P.
    Reitsma, Pieter H.
    Lindhout, Theo
    ten Cate, Hugo
    Spek, C. Arnold
    BLOOD, 2007, 110 (09) : 3176 - 3182
  • [27] Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage
    Jacques, SL
    Kuliopulos, A
    BIOCHEMICAL JOURNAL, 2003, 376 (03) : 733 - 740
  • [28] Polymorphism in the protease-activated receptor-4 gene region associates with platelet activation and perioperative myocardial injury
    Muehlschlegel, Jochen D.
    Perry, Tjoervi E.
    Liu, Kuang-Yu
    Fox, Amanda A.
    Smith, Shane A.
    Lichtner, Peter
    Collard, Charles D.
    Shernan, Stanton K.
    Hartwig, John H.
    Body, Simon C.
    Hoffmeister, Karin M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (02) : 161 - 166
  • [29] Activation of protease-activated receptor-4 inhibits the intrinsic excitability of colonic dorsal root ganglia neurons
    Karanjia, R.
    Spreadbury, I.
    Bautista-Cruz, F.
    Tsang, M. E.
    Vanner, S.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (11): : 1218 - 1221
  • [30] Repurposing Registered Drugs as Antagonists for Protease-Activated Receptor 2
    Xu, Weijun
    Lim, Junxian
    Goh, Chai-Yeen
    Suen, Jacky Y.
    Jiang, Yuhong
    Yau, Mei-Kwan
    Wu, Kai-Chen
    Liu, Ligong
    Fairlie, David P.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2015, 55 (10) : 2079 - 2084
12345